NATCO records increase in revenues, profits Oct 29, 2009
 

Hyderabad based NATCO Pharma Limited had recorded on a consolidated basis, revenues of the order of Rs. 119 Crores for the quarter ended on 30th September, 2009 as against Rs. 114 Crores for the same quarter last year. The net profit, after tax, for the quarter ended 30th September, 2009 amounted to Rs. 1337 lakhs as against Rs. 1187 lakhs for the same quarter last year.

 
NATCO confirms filing of ANDA for Generic Revlimid 31/08/2010
NATCO denies speculative news 23/08/2010
NATCO reports increased earnings and profits 31/07/2010
NATCO launches Anastrazole in the USA 29/06/2010
NATCO records higher sales, profits 25/06/2010
NATCO launches BENDIT 07/04/2010
NATCO declares an interim dividend of Rs. 2 per share 27/01/2010
Press Release 09/01/2010
NATCO records increase in revenues, profits 29/10/2009
Natco’s note on anti-cancer drug Albupax 19/10/2009
NATCO Pharma launches Swine Flu medicine 18/09/2009
NATCO’s partner – Mylan’s – ANDA accepted for review of Glatiramer Acetate 14/09/2009
News | Careers | Privacy Policy
NATCO House, Road No: 2, Banjara Hills, Hyderabad - 500 033
Powered by www.sholay.in